SEARCH

SEARCH BY CITATION

References

  • AGURELL, S., HALLDIN, M., LINDGREN, J.E., OHLSSON, A., WIDMAN, M., GILLESPIE, H. & HOLLISTER, L. (1986). Pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev., 38, 2143.
  • BAEK, S.H., SREBNIK, M. & MECHOULAM, R. (1985). Borontrifluoride on alumina–a modified Lewis acid reagent. An improved synthesis of cannabidiol. Tetrahedron Lett., 26, 10831086.
  • BAYEWITCH, M., RHEE, M.H., AVIDOR-REISS, T., BREUER, A., MECHOULAM, R. & VOGEL, Z. (1996). (−)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J. Biol. Chem., 271, 99029905.
  • BISOGNO, T., MAURELLI, S., MELCK, D., DE PETROCELLIS, L. & DI MARZO, V. (1997). Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem., 272, 33153323.
  • BORNHEIM, L.M. & CORREIA, M.A. (1989). Effect of cannabidiol on cytochrome P-450 isozymes. Biochem. Pharmacol., 38, 27892794.
  • BURSTEIN, S., HUNTER, S.A. & RENZULLI, L. (1985). Prostaglandins and cannabis XIV. Tolerance to the stimulatory actions of cannabinoids on arachidonate metabolism. J. Pharmacol. Exp. Ther., 235, 8791.
  • CATERINA, M.J., LEFFLER, A., MALMBERG, A.B., MARTIN, W.J., TRAFTON, J., PETERSEN-ZEITZ, K.R., KOLTZENBURG, M., BASBAUM, A.I. & JULIUS, D. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 306313.
  • CONSROE, P., MARTIN, A. & SINGH, V. (1981). Antiepileptic potential of cannabidiol analogs. J. Clin. Pharmacol., 21, 428S436S.
  • CRAVATT, B.F., GIANG, D.K., MAYFIELD, S.P., BOGER, D.L., LERNER, R.A. & GILULA, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 8387.
  • DAVIS, J.B., GRAY, J., GUNTHORPE, M.J., HATCHER, J.P., DAVEY, P.T., OVEREND, P., HARRIES, M.H., LATCHAM, J., CLAPHAM, C., ATKINSON, K., HUGHES, S.A., RANCE, K., GRAU, E., HARPER, A.J., PUGH, P.L., ROGERS, D.C., BINGHAM, S., RANDALL, A. & SHEARDOWN, S.A. (2000). Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 405, 183187.
  • DE PETROCELLIS, L., BISOGNO, T., DAVIS, J.B., PERTWEE, R.G. & DI MARZO, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 483, 5256.
  • DEVANE, W.A., BREUER, A., SHESKIN, T., JARBE, T.U.C., EISEN, M. & MECHOULAM, R. (1992a). A novel probe for the cannabinoid receptor. J. Med. Chem., 35, 20652069.
  • DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D. & MECHOULAM, R. (1992b). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • DIB, B. & FALCHI, M. (1996). Convulsions and death induced in rats by Tween 80 are prevented by capsaicin. Int. J. Tissue React., 18, 2731.
  • DI MARZO, V., BISOGNO, T., MELCK, D., ROSS, R., BROCKIE, H., STEVENSON, L., PERTWEE, R. & DE PETROCELLIS, L. (1998). Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett., 436, 449454.
  • DI MARZO, V., BREIVOGEL, C., BISOGNO, T., MELCK, D., PATRICK, G., TAO, Q., SZALLASI, A., RAZDAN, R.K. & MARTIN, B.R. (2000b). Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. Eur. J. Pharmacol., 406, 363374.
  • DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686691.
  • DI MARZO, V., LASTRES-BECKER, I., BISOGNO, T., DE PETROCELLIS, L., MILONE, A., DAVIS, J.B. & FERNANDEZ-RUIZ, J.J. (2001). Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur. J. Pharmacol., 420, 123131.
  • DI MARZO, V., MELCK, D., DE PETROCELLIS, L. & BISOGNO, T. (2000a). Cannabimimetic fatty acid derivatives in cancer and inflammation. Prostaglandins Other Lipid Mediat., 61, 4361.
  • GUIMARAES, F.S., DE AQUIAR, J.C., MECHOULAM, R. & BREUER, A. (1994). Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze. Gen. Pharmacol., 25, 161194.
  • HAMPSON, A.J., GRIMALDI, M., AXELROD, J. & WINK, D. (1998). Cannabidiol and (−) Delta-9-tetrahydrocannabinol are neuroprotective. Proc. Natl. Acad. Sci. U.S.A., 95, 82688273.
  • HANSEN, H.S., LAURITZEN, L., MOESGAARD, B., STRAND, A.M. & HANSEN, H.H. (1998). Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity. Biochem. Pharmacol., 55, 719725.
  • HAYES, P., MEADOWS, H.J., GUNTHORPE, M.J., HARRIES, M.H., DUCKWORTH, D.M., CAIRNS, W., HARRISON, D.C., CLARKE, C.E., ELLINGTON, K., PRINJHA, R.K., BARTON, A.J., MEDHURST, A.D., SMITH, G.D., TOPP, S., MURDOCK, P., SANGER, G.J., TERRETT, J., JENKINS, O., BENHAM, C.D., RANDALL, A.D., GLOGER, I.S. & DAVIS, J.B. (2000). Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain, 88, 205215.
  • HILLARD, C.J. & JARRAHIAN, A. (2000). The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids, 108, 123134.
  • HOLZER, P. (1991). Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev., 43, 143201.
  • HOWLETT, A.C., CHAMPION, T.M., WILKEN, G.H. & MECHOULAM, R. (1990). Stereochemical effects of 11-OH-delta-8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Neuropharmacology, 29, 161165.
  • JACOBSSON, S.O. & FOWLER, C.J. (2001). Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br. J. Pharmacol., 132, 17431754.
  • JARBE, T.U.C., HILTUNEN, A.J. & MECHOULAM, R. (1989). Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-OH-delta-8-tetra-hydrocannabinol in rats and pigeons. J. Pharmacol. Exper. Ther., 250, 10001005.
  • KHANOLKAR, A.D. & MAKRIYANNIS, A. (1999). Structure-activity relationships of anandamide, an endogenous cannabinoid ligand. Life Sci., 65, 607616.
  • LAMBERT, D.M. & DI MARZO, V. (1999). The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic Curr. Med. Chem., 6, 757773.
  • LEITE, J.R., CARLINI, E.A., LANDER, N. & MECHOULAM, R. (1982). Anticonvulsant effect of (−) and (+) isomers of CBD and their dimethyl heptyl homologs. Pharmacol., 124, 141146.
  • LITTLE, P.J., COMPTON, D.R., MECHOULAM, R. & MARTIN, B. (1989). Stereochemical effects of 11-OH-delta-8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behavior, 32, 661666.
  • LORTON, D., LUBAHN, C., ENGAN, C., SCHALLER, J., FELTEN, D.L. & BELLINGER, D.L. (2000). Local application of capsaicin into the draining lymph nodes attenuates expression of adjuvant-induced arthritis. Neuroimmunomodulation, 7, 115125.
  • MAINGRET, F., PATEL, A.J., LAZDUNSKI, M. & HONORE, E. (2001). The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J., 20, 4754.
  • MALFAIT, A.M., GALLILY, R., SUMARIWALLA, P.F., MALIK, A.S., ANDREAKOS, E., MECHOULAM, R. & FELDMANN, M. (2000). The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A., 97, 95619566.
  • MARTIN, A.R., CONSROE, P., KANE, V.V., SHAH, V., SINGH, V., LANDER, N., MECHOULAM, R. & SREBNIK, M. (1987). Structure-anticonvulsant activity relationships of cannabidiol analogs. NIDA Res. Monogr., 79, 4858.
  • MECHOULAM, R. (1999). Recent advantages in cannabinoid research. Forsch. Komplementarmed, 6, 1620.
  • MECHOULAM, R. & GAONI, Y. (1967). The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett., 11091111.
  • MECHOULAM, R. & SHVO, Y. (1963). The structure of cannabidiol. Tetrahedron, 19, 20732078.
  • MECHOULAM, R., FEIGENBAUM, J.J., LANDER, N., SEGAL, M., JARBE, T.U.C., HILTUNEN, A.J. & CONSROE, P. (1988). Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia, 44, 762764.
  • PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther., 74, 129180.
  • PERTWEE, R.G. (1999). Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem., 6, 635664.
  • RAKHSHAN, F., DAY, T.A., BLAKELY, R.D. & BARKER, E.L. (2000). Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther., 292, 960967.
  • ROSS, R.R., GIBSON, T.M., BROCKIE, H.C., LESLIE, M., PASHMI, G., CRAIB, S.J., DI MARZO, V. & PERTWEE, R.G. (2001). Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol., 132, 631640.
  • SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227230.
  • SRIVASTAVA, M.D., SRIVASTAVA, B.I. & BROUHARD, B. (1998). Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology, 40, 179185.
  • STRAUS, S.E. (2000). Immunoactive cannabinoids: therapeutic prospects for marijuana constituents. Proc. Natl. Acad. Sci. U.S.A., 97, 93639364.
  • SZALLASI, A. & BLUMBERG, P.M. (1999). Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev., 51, 159212.
  • SZALLASI, A. & DI MARZO, V. (2000). New perspectives on enigmatic vanilloid receptors. Trends Neurosci., 23, 491497.
  • TCHILIBON, S. & MECHOULAM, R. (2000). Synthesis of a primary metabolite of cannabidiol. Org. Lett., 2, 33013303.
  • TOMINAGA, M., CATERINA, M.J., MALMBERG, A.B., ROSEN, T.A., GILBERT, H., SKINNER, K., RAUMANN, B.E., BASBAUM, A.I. & JULIUS, D. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 21, 531543.
  • UEDA, N., PUFFENBARGER, R.A., YAMAMOTO, S. & DEUTSCH, D.G. (2000). The fatty acid amide hydrolase. Chem. Phys. Lipids, 108, 107121.
  • WATANABE, K., KAYANO, Y., MATSUNAGA, T., YAMAMOTO, I. & YOSHIMURA, H. (1996). Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol. Pharm. Bull., 19, 11091111.
  • ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.